Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 27, 2025
Metformin-Based Covalent Organic Frameworks With Excellent Biosafety and High Efficiency against Pathogenic Microorganisms
Jia-Yi Liu, Hong Jiang, Lei Ma, et al.
Journal of the American Chemical Society
|
September 4, 2024
3D Covalent Organic Frameworks with 16-Connectivity for Photocatalytic C(sp<sup>3</sup>)-C(sp<sup>2</sup>) Cross-Coupling
Meng Lu, Shuai-Bing Zhang, Run-Han Li, et al.
Molecular Carcinogenesis
|
April 17, 2023
Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer
Xiao-Rong Yang, Can Pi, Yi-Chen Zhang, et al.
Journal for Immunotherapy of Cancer
|
July 18, 2023
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
Jia-Yi Deng, Qing Gou, Lingling Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2021
Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments
Mei-Mei Zheng, Hai-Yan Tu, Jin-Ji Yang, et al.
Oncoimmunology
|
April 11, 2024
Redox<sup>high</sup> phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma
Xue-Wu Wei, Chang Lu, Yi-Chen Zhang, et al.
Science Bulletin
|
January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Journal of Translational Medicine
|
April 2, 2024
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, et al.
Eclinicalmedicine
|
October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated <i>EGFR</i>-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 27, 2025
Metformin-Based Covalent Organic Frameworks With Excellent Biosafety and High Efficiency against Pathogenic Microorganisms
Jia-Yi Liu, Hong Jiang, Lei Ma, et al.
Journal of the American Chemical Society
|
September 4, 2024
3D Covalent Organic Frameworks with 16-Connectivity for Photocatalytic C(sp<sup>3</sup>)-C(sp<sup>2</sup>) Cross-Coupling
Meng Lu, Shuai-Bing Zhang, Run-Han Li, et al.
Molecular Carcinogenesis
|
April 17, 2023
Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer
Xiao-Rong Yang, Can Pi, Yi-Chen Zhang, et al.
Journal for Immunotherapy of Cancer
|
July 18, 2023
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
Jia-Yi Deng, Qing Gou, Lingling Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2021
Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments
Mei-Mei Zheng, Hai-Yan Tu, Jin-Ji Yang, et al.
Oncoimmunology
|
April 11, 2024
Redox<sup>high</sup> phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma
Xue-Wu Wei, Chang Lu, Yi-Chen Zhang, et al.
Science Bulletin
|
January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Journal of Translational Medicine
|
April 2, 2024
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, et al.
Eclinicalmedicine
|
October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated <i>EGFR</i>-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.
Page
of 3